$56.73+0.36 (+0.64%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Liquidia (LQDA) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
30 figures withheld by our checks. Each blank figure names its reason.
Business engineGrowing fast: revenue compounds ~87.3%/yr (FY21→FY25), net margin −43.5%. Worth your attention in FY25: Share count (+73.2%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲1031.2%
158.3
FY21→FY25CAGR +87.3%/yr
Net income ($M)▲46.3%
−68.9
FY21→FY25CAGR —
Free cash flow ($M)▲59.3%
−40.0
FY21→FY25CAGR —
Diluted EPS▲50.9%
−0.80
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+73.2%
49.7mn → 86.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$4.3M
steady at 2.7% of revenue (−12.4% YoY).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-44¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 76.5% → 91.6%. Net margin -43.5% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 621,865.0 | 158,320.0 | 13,996.0 | 17,488.0 | 15,935.0 | 12,853.0 | ▲1031.2% | +87.3% |
Cost of revenue | 45,234.0 | 13,242.0 | 5,879.0 | 2,888.0 | 2,859.0 | 3,023.0 | ▲125.2% | +44.7% |
Gross profit | 576,631.0 | 145,078.0 | 8,117.0 | 14,600.0 | 13,076.0 | 9,830.0 | ▲1687.3% | +96.0% |
Research & development | 71,967.0 | 39,276.0 | 47,842.0 | 43,242.0 | 19,435.0 | 20,517.0 | ▼17.9% | +17.6% |
Selling, general & admin | 211,626.0 | 157,178.0 | 81,569.0 | 44,742.0 | 32,411.0 | 23,110.0 | ▲92.7% | +61.5% |
Total operating expenses | 673,342.0 | 196,454.0 | 129,411.0 | 87,984.0 | 51,846.0 | 43,627.0 | ▲51.8% | +45.7% |
Operating incomefeeds ROC rank | −96,711.0 | −51,376.0 | −121,294.0 | −73,384.0 | −38,770.0 | −33,797.0 | ▲57.6% | — |
Other income, net | −16,654.0 | −17,548.0 | −6,997.0 | −5,118.0 | −2,245.0 | −782.0 | — | — |
Pretax income | −113,365.0 | −68,924.0 | −128,291.0 | −78,502.0 | −41,015.0 | −34,579.0 | ▲46.3% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −94,189.0 | −68,924.0 | −128,291.0 | −78,502.0 | −41,015.0 | −34,579.0 | ▲46.3% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −1.20 | −0.80 | −1.63 | −1.21 | −0.67 | −0.70 | ▲50.9% | — |
Diluted shares (mn) | 89.52 | 86.06 | 78.71 | 64.99 | 60.96 | 49.68 | ▲9.3% | +14.7% |
| Margins | ||||||||
Gross margin89th pct in Healthcare | 92.7% | 91.6% | 58.0% | 83.5% | 82.1% | 76.5% | ▲33.6pp | +15.2pp |
Operating margin | −15.6% | −32.5% | −866.6% | −419.6% | −243.3% | −263.0% | ▲834.2pp | +230.5pp |
Net margin24th pct in Healthcare | −15.1% | −43.5% | −916.6% | −448.9% | −257.4% | −269.0% | ▲873.1pp | +225.5pp |
† TTM = trailing four quarters through 2026-09-30.
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-05 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Liquidia's revenue last fiscal year?
Liquidia reported revenue of $158.3M in fiscal 2025, up 1031.2% from fiscal 2024.
What was Liquidia's net income?
Liquidia reported net income of −$68.9M in fiscal 2025, a net margin of −43.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

